Christian Fernández García

Barclays Bank SA provides commercial banking services. It offers services such as deposits, mortgages, mutual funds, pension plans, insurance, private banking, consumer finance, asset management, financial advices and non-financial advice. Its services include fund transfers, excess liquidity, operating finance, foreign trade, strategic financing and risk management. The bank has a network of 500 branches in Spain. Barclays Bank was founded on June 6, 1946 and is headquartered in Madrid, Spain.

Advancell Advanced In Vitro Cell Technologies SL is a holding company engaged in the design, development, and testing of pharmaceutical products. It focuses on indications in the areas of oncology, dermatology, and neurology. Its pipeline consists of medications for hand-food syndrome, chronic lymphocytic leukemia, multiple sclerosis, psoriasis, and myelodysplastic syndromes. These are then licensed to affiliates for manufacturing and distribution. The company was founded by Susana Castel-Gil, Senen Vilar, and Manuel Reina in 2001, and is headquartered in Barcelona, Spain.

Era Biotech SA is a biotechnology company that specializes in enzymes and recombinant vaccines. It develops and produces vaccines for human and animal health, therapeutic peptides, and industrial enzymes. The company was founded in August 2002 and is headquartered in Barcelona, Spain.

BCNNet Translations SL provides professional translation services. Its solutions include multimedia, tools and technology, machine translation, proofreading and editing and digital printing. The company was founded by Francesc Saldana in 1997 and is headquartered in Barcelona, Spain.

AMR Systems SL develops products for wireless communication. The firm provides cordless communication technology for data transmission and links in the telecommunications industry. Its products streamdata, streamnet, and streamserver offer integrated wireless solution for remote monitoring and data-acquisition in metering and SCADA systems. The company was founded by Mario Comas Romero and Carles Perelló García in March 1999 and is headquartered in Barcelona, Spain.

Crystax Pharmaceuticals is the first Spanish biotech dedicated to structure-based drug discovery. Located in Barcelona, Crystax was founded in 2002 by recognized scientists Miquel Coll and Juan Aymamí seeking to apply their structural biology knowledge and experience to the drug discovery process. Its mission is to find the best possible drug in the shortest time and with the highest rate of success. They aim to achieve this mission through its B2D2™ platform and the commitment of its team. Its biophysics based drug discovery platform B2D2™, covers the entire process from target cloning to lead optimization. Through structure determination of target proteins with the fragment hits, they obtain key structural information for the design of new compounds. They also use biophysical characterization to guide the follow-up of the initial hits. The result is an acceleration of the drug discovery process

Genmedica Therapeutics SL engages in the research and development of new treatments for diabetes. Its has developed novel NCE-generating platform to generate dual action, small molecules that act against oxidative stress and inflammation, two specific pathways known to be critical in the root causes of the disease. The company was founded by Alec Humayun Mian and Luc Marti Clauzel on June 21, 2004 and is headquartered in Barcelona, Spain.

Fractus SA designs and manufactures fractal antennas for wireless devices. It also provides technical consulting and custom product engineering. The company was founded by Carles Puente, Ruben Bonet and Luis Fradera in March 1999 and is headquartered in Barcelona, Spain.